-
Obstructive sleep apnea causes a variety of alterations in the control of cerebral blood flow, contributing to the risk for stroke.
-
Confocal microscopy of the cornea may be a useful diagnostic test to identify patients with small-fiber neuropathies.
-
Concern about serotonin syndrome should not prevent migraineurs who have mood disorders from being treated judiciously with the combination of triptans and serotonergic medications.
-
-
A great debate continues regarding appropriate management of hypertension during acute stroke. In the U.S., permissive hypertension is popular with recommendations that antihypertensive medications be discontinued when an acute ischemic stroke occurs.
-
Lorcaserin submitted for FDA review, FDA advisory panel votes against phentermine/topiramate, mixed vote on rosiglitazone, advisory panel votes to remove breast cancer indication from bevacizumab labeling, no increase in seizures found with DTaP vaccine, new REMS for quinine.
-
-
Vital exhaustion predicts long-term risk for adverse cardiac events in men and women, independent of established biomedical risk factors.
-
A new three-drug antihypertensive pill, combining an angiotensin II receptor antagonist (olmesartan [OLM]), a calcium channel blocker (amlodipine [AML]), and a thiazide diuretic (hydrochlorothiazide [HCTZ]), has been approved by the FDA. The new combination is marketed by Daiichi Sankyo as Tribenzor.
-
Lorcaserin submitted for FDA review, FDA advisory panel votes against phentermine/topiramate, mixed vote on rosiglitazone, advisory panel votes to remove breast cancer indication from bevacizumab labeling, no increase in seizures found with DTaP vaccine, new REMS for quinine.
